Bone disease after renal transplantation.

Area of Science:

• Nephrology
• Endocrinology
• Orthopedics

Background:

• Bone mineral density (BMD) rapidly decreases post-renal transplant, persisting for years.
• This bone loss elevates fracture risk, potentially exceeding that in dialysis patients.
• The correlation between BMD and fractures in transplant patients remains debated.

Purpose of the Study:

• To review the multifaceted nature of bone disease following renal transplantation.
• To explore contributing factors including pre-transplant bone health and immunosuppressive therapy.
• To discuss potential therapeutic interventions and the need for further research.

Main Methods:

• Literature review of bone disease post-renal transplantation.
• Analysis of factors contributing to bone loss and fracture risk.
• Evaluation of current and potential treatment strategies.

Main Results:

• Post-transplant bone disease is a complex disorder involving renal osteodystrophy.
• Multiple factors contribute, including immunosuppressants, hypophosphatemia, and calcium-vitamin D imbalances.
• Histological findings show reduced bone formation and increased apoptosis.

Conclusions:

• Bisphosphonates and vitamin D metabolites show promise for early bone loss prevention.
• Caution is advised with bisphosphonates, especially in low bone turnover states.
• Further controlled trials are necessary to confirm long-term efficacy in renal transplant patients.